News
Hepatitis C
- Boceprevir Boosts Hepatitis C Treatment Success 8/11/2010
- Vertex: telaprevir could shorten hep C treatment 8/11/2010
- Three Rivers Pharmaceuticals Announces FDA Approval Of Expanded Labeling of INFERGEN 7/6/2010
- Old Drugs May Have New Use Against Hepatitis C 6/9/2010
- Interim results from ZALBIN Phase 2B trial in chronic hepatitis C patients announced 3/26/2010
- Abbott, Enanta moving Hepatitis C drug development 3/3/2010
- Novartis Gains Exclusive Rights 2/18/2010
- Liver Cancer Risks 2/9/2010